OTL -101 has received a rare paediadriatric disease announced by orchard therapeutics

Orchard Therapeutics Limited , a clinical-stage biotechnology company announce that the US FDA granted a Rare Paediatric Disease Designation to OTL-101.

EC Grants Marketing Authorization for Gilead Vosevi for the Treatment of All Genotypes of Chronic Hepatitis C

Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Vosevi, as a once-daily single tablet regimen for the treatment of adults with genotype 1-6 chronic...

RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Phase III Study with RHB-104 for Crohn Disease

RedHill Biopharma Ltd reported, following a second pre-planned meeting to assess the safety and efficacy data from its ongoing first Phase III study with RHB-104 for Crohn disease...

Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017

Clinical and laboratory personnel with the need to store vaccines, pharmaceuticals and other molecular or biological samples safely can benefit from a new series of lab-grade undercounter...

Novel approaches to improved treatments for orphan genetic diseases

Orphan genetic diseases have become an increasingly popular area for drug development he development of a means to restore missing proteins to diseased cells consistently...

Priorclave announce Printer up-grade on lab autoclaves, improving customer experience

Now available on all new laboratory autoclaves and research grade sterilisers leaving the Priorclave production where a printer is required will benefit from inclusion of a new thermal printer.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com